Oramed Pharmaceuticals Reports Positive Top-Line Data From U.S. Phase IIa Trial With Oral Insulin In Type 1 Diabetes

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.